#M_and_A

ORIX signed a contract on April 13, 2026, to transfer all interests in consolidated subsidiary IX NTI Holdings, LLC to a special purpose company established by Olympus. The transfer consideration is undisclosed.

Nexcera Pharma has achieved milestone payments up to USD 694 million (approx. JPY 110.9 billion) in its alliance with Eli Lilly, already factored into earnings guidance for the fiscal year ending December 2026.

The Hachijūni Bank, Ltd. and its wholly owned subsidiary, The Nagano Bank, Ltd., merged on January 1, 2026, commencing operations under the name The Hachijūni Nagano Bank, Ltd.

PHC Holdings has resolved to transfer the Continuous Glucose Monitoring (CGM) system Eversense sales business of its consolidated subsidiary Ascensia Diabetes Care Holdings AG to Senseonics Holdings, Inc. for 1.1 million USD plus the net amount of transferred assets and liabilities, effective January 1, 2026.

Completed acquisition of all 10,000 shares of Matsufuji Co., Ltd., making it a subsidiary. Goodwill estimated at approximately 7.6 billion yen, with an amortization period of 10 years. Effective January 5, 2026.

On January 1, 2026, our subsidiary Gunma Beverage Co., Ltd. will acquire the fixed assets of the Gunma Factory from Pokka Sapporo Food & Beverage Ltd., aiming to expand production volume.